Syngene International Limited is a contract research company. The Company is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its services include discovery chemistry and biology services, toxicology, pharmaceutical development, process development/manufacture of intermediates, active pharmaceutical ingredients and bio-therapeutics. Its services encompass integrated, discovery and development services for novel molecular entities (NMEs) across industrial sectors, including pharmaceutical, biopharmaceutical and biotechnology, among others. It specializes in conducting discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, and stability studies) and manufacturing (scale-up, pre-clinical and manufacturing supplies). It serves clients ranging from multinational corporations to start-ups.